Why Pfizer Remains A Strong Buy In 2026
Source: SeekingAlpha
2026-03-27 10:46:44 ET
After Pfizer's Q4 report ( PFE ), which, as you know, was published on February 3, its stock was up 7%, outperforming the S&P 500 ( SPY ) [-5.7% return]. (These results came in after my last update on Pfizer, which was in January .)...
Read the full article on Seeking Alpha
For further details see:
Why Pfizer Remains A Strong Buy In 2026
Pfizer Inc.
NASDAQ: PFE
PFE Trading
1.33% G/L:
$28.245 Last:
17,577,164 Volume:
$28.27 Open:
PFE Latest News
PFE Stock Data
$156,612,814,520
5,628,850,476
0.02%
1712
N/A
Pharmaceuticals
Healthcare
US
New York
